Maravai LifeSciences Holdings, Inc. (MRVI) Documents: SEC Filings, Investor Presentations & Press Releases

Maravai LifeSciences Holdings, Inc. (MRVI) documents, SEC filings and the IR site together: 154 documents, newest first; latest 2026-08-07. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-07DeckInvestor Presentation - August 2026
2026-08-0710-QForm 10-Q for the quarter ended Jun 30
2026-08-06Press releaseMaravai LifeSciences Reports Second Quarter 2026 Financial Results
2026-08-06DeckEarnings presentation · Q2 2026 · Aug 2026
2026-08-06SupplementGAAP/Non-GAAP reconciliation · Q2 2026
2026-08-068-KForm 8-K, Item 2.02 results
2026-07-22Press releaseMaravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
2026-07-20Press releaseTriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping
2026-06-16Press releaseTriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
2026-06-03Press releaseMaravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
2026-06-038-KForm 8-K, Item 1.01
2026-05-298-KForm 8-K, Item 5.07
2026-05-18Press releaseMaravai LifeSciences To Attend The Jefferies Global Healthcare Conference
2026-05-08DeckInvestor Presentation - May 2026
2026-05-0810-QForm 10-Q for the quarter ended Mar 31
2026-05-07Press releaseMaravai LifeSciences Reports First Quarter 2026 Financial Results
2026-05-07Press releasePress release · Q1 2026 · May 2026
2026-05-07DeckEarnings presentation · Q1 2026 · May 2026
2026-05-07SupplementGAAP/Non-GAAP reconciliation · Q1 2026
2026-05-078-KForm 8-K, Item 2.02 results
2026-04-24ProxyDefinitive proxy statement
2026-04-20Press releaseMaravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
2026-02-2610-KAnnual report on Form 10-K, FY25
2026-02-25DeckEarnings presentation · Q4 2025 · Feb 2026
2026-02-25SupplementGAAP/Non-GAAP reconciliation · Q4 2025
2026-02-258-KForm 8-K, Item 2.02 results
2026-02-09Press releaseMaravai LifeSciences To Host Earnings Conference Call on Wednesday · Q4 2025
2025-11-10Press releaseMaravai LifeSciences Announces November 2025 Investor Conference Schedule
2025-11-0710-QForm 10-Q for the quarter ended Sep 30
2025-11-06SupplementQ3 2025 Reconciliation of Non-GAAP Financial Information
2025-11-06DeckQ3 2025 Financial Results
2025-11-068-KForm 8-K, Item 2.02 results
2025-10-278-KForm 8-K, Item 5.02
2025-08-11Press releaseMaravai LifeSciences Reports Second Quarter 2025 Financial Results
2025-08-11SupplementQ2 2025 Reconciliation of Non-GAAP Financial Information
2025-08-11DeckQ2 2025 Financial Results
2025-08-118-KForm 8-K, Item 2.02 results
2025-08-1110-QForm 10-Q for the quarter ended Jun 30
2025-07-188-KForm 8-K, Item 4.01
2025-06-258-KForm 8-K, Item 5.02

MRVI overview · MRVI earnings · MRVI financials · MRVI KPIs · MRVI ownership · MRVI peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.